Arcadia Biosciences Files 8-K, Moves HQ to Dallas
Ticker: RKDA · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing-update, hq-move
TL;DR
Arcadia Biosciences is moving its HQ to Dallas, TX. New address and phone number filed.
AI Summary
Arcadia Biosciences, Inc. reported a material definitive agreement on March 28, 2025. The company, incorporated in Delaware, filed an 8-K form with the SEC. The filing indicates a change in principal executive offices to Dallas, Texas, with a new phone number provided.
Why It Matters
This filing signals a significant operational change for Arcadia Biosciences, potentially impacting its strategic direction and investor relations due to the relocation of its principal executive offices.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure regarding a change in address and does not inherently present new financial or operational risks.
Key Numbers
- 001-37383 — Commission File Number (SEC identifier for Arcadia Biosciences)
- 81-0571538 — IRS Employer Identification No. (Tax identification for Arcadia Biosciences)
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- March 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Dallas, Texas (location) — New Principal Executive Offices
- 214 974-8921 (phone_number) — Registrant's Telephone Number
FAQ
What is the specific nature of the material definitive agreement mentioned in the filing?
The filing does not specify the nature of the material definitive agreement, only that it is the reason for the 8-K filing.
When was the change in principal executive offices effective?
The filing states the date of the earliest event reported is March 28, 2025, which is when the change in principal executive offices is implicitly effective.
What was Arcadia Biosciences' previous principal executive office address?
The filing does not explicitly state the previous address, only the new address in Dallas, Texas.
What is the SIC code listed for Arcadia Biosciences?
The SIC code listed is 1311 for CRUDE PETROLEUM & NATURAL GAS, which appears to be an error given the company's name.
Is the filing related to financial statements or exhibits?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item information.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Arcadia Biosciences, Inc. (RKDA).